Premier singles out Snoretox in Breakthrough Victoria Funding Announcement 23.6.22
Snoretox was today singled out in the announcement by Premier Dan Andrews and Treasurer Tim Pallas of $100 million for the Breakthrough Victoria – University Innovation Platform.
Snoretox is another example of a company commercialising RMIT-developed technology – a novel muscle toning toxin-based therapeutic for treating sleep apnea and snoring, as well as a range of other weak muscle conditions such as incontinence.
Breakthrough Victoria is backing great ideas that will save lives, change the way we live and provide jobs for the generations that will follow us.
Read the full media release here